Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits

Virology Journal

Anna-Lise Williamson³  Ed P Rybicki⁴  Michael-John Freeborough¹  Inga I Hitzeroth⁴  Jennifer Moodley²  Hans J Maree¹  Beatrix Coetzee¹  Anna T Salimo⁴  Tracy L Meiring⁴ 

[1] Department of Genetics, University of Stellenbosch, Stellenbosch, 7600, South Africa;School of Public Health and Family Medicine, University of Cape Town, Cape Town, Observatory, 7925, South Africa;National Health Laboratory Service, Groote Schuur Hospital, Cape Town, 7925, South Africa;Department of Molecular and Cell Biology, University of Cape Town, Rondebosch, 7700, South Africa

关键词: Rolling circle amplification;    Next generation sequencing;    Human immunodeficiency virus;    Human papillomavirus;   

Others  :  1154110
DOI  :  10.1186/1743-422X-9-164

 received in 2012-02-01, accepted in 2012-08-08,  发布年份 2012

【 摘 要 】

Background

Human papillomavirus (HPV) is the aetiological agent for cervical cancer and genital warts. Concurrent HPV and HIV infection in the South African population is high. HIV positive (+) women are often infected with multiple, rare and undetermined HPV types. Data on HPV incidence and genotype distribution are based on commercial HPV detection kits, but these kits may not detect all HPV types in HIV + women. The objectives of this study were to (i) identify the HPV types not detected by commercial genotyping kits present in a cervical specimen from an HIV positive South African woman using next generation sequencing, and (ii) determine if these types were prevalent in a cohort of HIV-infected South African women.

Methods

Total DNA was isolated from 109 cervical specimens from South African HIV + women. A specimen within this cohort representing a complex multiple HPV infection, with 12 HPV genotypes detected by the Roche Linear Array HPV genotyping (LA) kit, was selected for next generation sequencing analysis. All HPV types present in this cervical specimen were identified by Illumina sequencing of the extracted DNA following rolling circle amplification. The prevalence of the HPV types identified by sequencing, but not included in the Roche LA, was then determined in the 109 HIV positive South African women by type-specific PCR.

Results

Illumina sequencing identified a total of 16 HPV genotypes in the selected specimen, with four genotypes (HPV-30, 74, 86 and 90) not included in the commercial kit. The prevalence’s of HPV-30, 74, 86 and 90 in 109 HIV positive South African women were found to be 14.6%, 12.8%, 4.6% and 8.3% respectively.

Conclusions

Our results indicate that there are HPV types, with substantial prevalence, in HIV positive women not being detected in molecular epidemiology studies using commercial kits. The significance of these types in relation to cervical disease remains to be investigated.

【 授权许可】

   
2012 Meiring et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22:2675-2686.
• [2]Allan B, Marais DJ, Hoffman M, Shapiro S, Williamson AL: Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies. J Clin Microbiol 2008, 46:740-742.
• [3]Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
• [4]Gormley RH, Kovarik CL: Dermatologic manifestations of HPV in HIV-infected individuals. Curr HIV/AIDS Rep 2009, 6:130-138.
• [5]Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
• [6]Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V: A review of human carcinogens--Part B: biological agents. Lancet Oncol 2009, 10:321-322.
• [7]de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al.: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048-1056.
• [8]Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
• [9]McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA: Women with HIV are more commonly infected with non-16 and −18 high-risk HPV types. Gynecol Oncol 2010, 116:572-577.
• [10]National Department of Health of South Africa: National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2009.Annual report. Pretoria; 2010.
• [11]Firnhaber C, Zungu K, Levin S, Michelow P, Montaner LJ, McPhail P, Williamson AL, Allan BR, Van der Horst C, Rinas A, Sanne I: Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol 2009, 53:10-17.
• [12]Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL: Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009, 199:1514-1524.
• [13]Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL: Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer 2009, 9:275. BioMed Central Full Text
• [14]Clifford GM, Goncalves MA, Franceschi S: Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20:2337-2344.
• [15]Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Van Doorn LJ: High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345.
• [16]Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236.
• [17]Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, JFS P, Petry KU, Kruger Kjaer S, Munk C, Iftner T: Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 2008, 80:1264-1274.
• [18]Jiang M, Xi LF, Edelstein ZR, Galloway DA, Olsem GJ, Lin WC, Kiviat NB: Identification of recombinant human papillomavirus type 16 variants. Virology 2009, 394:8-11.
• [19]Eklund C, Zhou T, Dillner J: Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 2010, 48:4147-4155.
• [20]Mori S, Nakao S, Kukimoto I, Kusumoto-Matsuo R, Kondo K, Kanda T: Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci 2011, 102:1223-1227.
• [21]Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T: Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2010, 48:143-149.
• [22]Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N: Application of next-generation sequencing technologies in virology. J Gen Virol 2012, 30:30.
• [23]Zerbino DR, Birney E: Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008, 18:821-829.
• [24]Bravo IG, de Sanjose S, Gottschling M: The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol 2010, 18:432-438.
• [25]Barzon L, Militello V, Lavezzo E, Franchin E, Peta E, Squarzon L, Trevisan M, Pagni S, Dal Bello F, Toppo S, Palu G: Human papillomavirus genotyping by 454 next generation sequencing technology. J Clin Virol 2011, 52:93-97.
• [26]Nelson JR, Cai YC, Giesler TL, Farchaus JW, Sundaram ST, Ortiz-Rivera M, Hosta LP, Hewitt PL, Mamone JA, Palaniappan C, Fuller CW: TempliPhi, phi29 DNA polymerase based rolling circle amplification of templates for DNA sequencing. Biotechniques 2002, Suppl:44-47.
• [27]Johne R, Muller H, Rector A, van Ranst M, Stevens H: Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Trends Microbiol 2009, 17:205-211.
• [28]Lowe B, Kobayashi L, Lorincz A, Mallonee R, O'Neil D, Thai H, Nazarenko I: HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP. J Mol Diagn 2010, 12:847-853.